TherapeuticsMD Inc
NASDAQ:TXMD
Balance Sheet
Balance Sheet Decomposition
TherapeuticsMD Inc
TherapeuticsMD Inc
Balance Sheet
TherapeuticsMD Inc
| Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
54
|
51
|
65
|
132
|
127
|
162
|
161
|
81
|
65
|
38
|
4
|
5
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
54
|
51
|
65
|
132
|
127
|
162
|
161
|
81
|
65
|
38
|
4
|
5
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
6
|
4
|
11
|
24
|
32
|
0
|
0
|
3
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
5
|
4
|
11
|
24
|
32
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
3
|
12
|
8
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
2
|
1
|
7
|
11
|
11
|
8
|
55
|
17
|
4
|
4
|
|
| Total Current Assets |
1
|
1
|
0
|
0
|
1
|
1
|
5
|
59
|
56
|
71
|
139
|
140
|
187
|
208
|
128
|
120
|
55
|
12
|
12
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
13
|
12
|
9
|
8
|
7
|
6
|
|
| PP&E Gross |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
13
|
12
|
9
|
8
|
7
|
0
|
|
| Accumulated Depreciation |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
24
|
45
|
41
|
7
|
7
|
6
|
4
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
18
|
16
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
2
|
1
|
0
|
0
|
1
|
1
|
0
|
34
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-74%
|
0
-80%
|
1
+700%
|
1
+50%
|
1
+17%
|
6
+321%
|
62
+951%
|
59
-5%
|
74
+25%
|
143
+93%
|
143
+0%
|
212
+48%
|
266
+25%
|
182
-32%
|
170
-7%
|
91
-47%
|
43
-52%
|
39
-10%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
6
|
3
|
7
|
4
|
23
|
19
|
21
|
3
|
2
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
7
|
7
|
7
|
12
|
20
|
26
|
11
|
17
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
188
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
2
|
7
|
14
|
12
|
51
|
27
|
4
|
3
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
0
|
3
|
4
|
7
|
11
|
11
|
15
|
13
|
41
|
53
|
59
|
253
|
47
|
7
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
73
|
195
|
238
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
10
|
9
|
7
|
6
|
|
| Total Liabilities |
0
N/A
|
0
-50%
|
0
N/A
|
1
N/A
|
0
-83%
|
3
+1 500%
|
7
+131%
|
7
-1%
|
11
+47%
|
11
N/A
|
15
+40%
|
13
-11%
|
115
+761%
|
257
+124%
|
306
+19%
|
263
-14%
|
55
-79%
|
14
-75%
|
11
-18%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
1
|
2
|
4
|
17
|
52
|
81
|
135
|
220
|
310
|
387
|
519
|
695
|
879
|
1 051
|
939
|
950
|
952
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
2
|
5
|
15
|
51
|
135
|
183
|
283
|
437
|
516
|
617
|
704
|
755
|
958
|
975
|
979
|
979
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
0
-76%
|
0
N/A
|
0
N/A
|
1
N/A
|
2
N/A
|
1
+18%
|
55
N/A
|
48
-12%
|
63
+30%
|
128
+102%
|
130
+2%
|
98
-25%
|
9
-91%
|
124
N/A
|
94
+25%
|
35
N/A
|
29
-17%
|
27
-7%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-74%
|
0
-80%
|
1
+700%
|
1
+50%
|
1
+17%
|
6
+321%
|
62
+951%
|
59
-5%
|
74
+25%
|
143
+93%
|
143
+0%
|
212
+48%
|
266
+25%
|
182
-32%
|
170
-7%
|
91
-47%
|
43
-52%
|
39
-10%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
5
|
5
|
6
|
9
|
10
|
12
|
12
|
|
| Preferred Shares Outstanding |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|